Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Emerg Infect Dis ; 22(9): 1604-12, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27533474

RESUMEN

We describe the epidemiology, clinical features, and molecular characterization of enterohemorrhagic Escherichia coli (EHEC) infections caused by the singular hybrid pathotype O80:H2, and we examine the influence of antibiotics on Shiga toxin production. In France, during 2005-2014, a total of 54 patients were infected with EHEC O80:H2; 91% had hemolytic uremic syndrome. Two patients had invasive infections, and 2 died. All strains carried stx2 (variants stx2a, 2c, or 2d); the rare intimin gene (eae-ξ); and at least 4 genes characteristic of pS88, a plasmid associated with extraintestinal virulence. Similar strains were found in Spain. All isolates belonged to the same clonal group. At subinhibitory concentrations, azithromycin decreased Shiga toxin production significantly, ciprofloxacin increased it substantially, and ceftriaxone had no major effect. Antibiotic combinations that included azithromycin also were tested. EHEC O80:H2, which can induce hemolytic uremic syndrome complicated by bacteremia, is emerging in France. However, azithromycin might effectively combat these infections.


Asunto(s)
Escherichia coli Enterohemorrágica/clasificación , Escherichia coli Enterohemorrágica/genética , Síndrome Hemolítico-Urémico/epidemiología , Síndrome Hemolítico-Urémico/microbiología , Adolescente , Adulto , Antibacterianos/farmacología , Niño , Preescolar , Brotes de Enfermedades , Farmacorresistencia Bacteriana , Escherichia coli Enterohemorrágica/metabolismo , Escherichia coli Enterohemorrágica/patogenicidad , Femenino , Estudios de Seguimiento , Francia/epidemiología , Genotipo , Geografía Médica , Síndrome Hemolítico-Urémico/diagnóstico , Síndrome Hemolítico-Urémico/tratamiento farmacológico , Humanos , Incidencia , Lactante , Masculino , Pruebas de Sensibilidad Microbiana , Tipificación de Secuencias Multilocus , Serogrupo , Serotipificación , Toxina Shiga/biosíntesis , Toxina Shiga/genética , Virulencia , Factores de Virulencia/genética , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA